Ricardo
Gómez García
Publications dans lesquelles il/elle collabore avec Ricardo Gómez García (17)
2013
-
p.D1690N Nav1.5 rescues p.G1748D mutation gating defects in a compound heterozygous Brugada syndrome patient
Heart Rhythm, Vol. 10, Núm. 2, pp. 264-272
2008
-
Effects of MiRP1 and DPP6 β-subunits on the blockade induced by flecainide of K V4.3/KChIP2 channels
British Journal of Pharmacology, Vol. 154, Núm. 4, pp. 774-786
-
Nitric oxide inhibits Kv4.3 and human cardiac transient outward potassium current (Ito1)
Cardiovascular Research, Vol. 80, Núm. 3, pp. 375-384
-
The HERACLES cardiovascular network
Revista Espanola de Cardiologia, Vol. 61, Núm. 1, pp. 66-75
2007
-
Effects of atorvastatin and simvastatin on atrial plateau currents
Journal of Molecular and Cellular Cardiology, Vol. 42, Núm. 5, pp. 931-945
-
Genetically engineered mice as a model for studying cardiac arrhythmias
Frontiers in Bioscience, Vol. 12, Núm. 1, pp. 22-38
-
Ivabradina, un bloqueador selectivo de la corriente If. Aspectos farmacológicos y tolerabilidad
Revista Espanola de Cardiologia Suplementos, Vol. 7, Núm. D
-
Lipid-lowering therapy with statins, a new approach to antiarrhythmic therapy
Pharmacology and Therapeutics, Vol. 114, Núm. 1, pp. 107-126
2006
-
Association of 14-3-3 proteins to β1-adrenergic receptors modulates Kv11.1 K+ channel activity in recombinant systems
Molecular Biology of the Cell, Vol. 17, Núm. 11, pp. 4666-4674
-
Características farmacológicas de los ARA-II. ¿Son todos iguales?
Revista Espanola de Cardiologia Suplementos, Vol. 6, Núm. C
-
Effects of nitric oxide on cardiac function
Revista Espanola de Cardiologia Suplementos, Vol. 6, Núm. A
-
Mecanismo de acción de la eplerenona
Revista Espanola de Cardiologia Suplementos, Vol. 6, Núm. B
-
Nitric oxide blocks hKv1.5 channels by S-nitrosylation and by a cyclic GMP-dependent mechanism
Cardiovascular Research, Vol. 72, Núm. 1, pp. 80-89
2005
-
Angiotensin II, angiotensin II antagonists and spironolactone and their modulation of cardiac repolarization
Trends in Pharmacological Sciences, Vol. 26, Núm. 3, pp. 155-161
-
Spironolactone and its main metabolite canrenoic acid block hKv1.5, Kv4.3 and Kv7.1 + minK channels
British Journal of Pharmacology, Vol. 146, Núm. 1, pp. 146-161
2004
-
Diltiazem inhibits hKv1.5 and Kv4.3 currents at therapeutic concentrations
Cardiovascular Research, Vol. 64, Núm. 3, pp. 457-466
-
Interaction of angiotensin II with the angiotensin type 2 receptor inhibits the cardiac transient outward potassium current
Cardiovascular Research, Vol. 62, Núm. 1, pp. 86-95